These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 7979274

  • 1. Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection.
    Chen M, Theander TG, Christensen SB, Hviid L, Zhai L, Kharazmi A.
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1470-5. PubMed ID: 7979274
    [Abstract] [Full Text] [Related]

  • 2. The novel oxygenated chalcone, 2,4-dimethoxy-4'-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivo.
    Chen M, Brøgger Christensen S, Zhai L, Rasmussen MH, Theander TG, Frøkjaer S, Steffansen B, Davidsen J, Kharazmi A.
    J Infect Dis; 1997 Nov; 176(5):1327-33. PubMed ID: 9359735
    [Abstract] [Full Text] [Related]

  • 3. Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum.
    Sharma N, Mohanakrishnan D, Sharma UK, Kumar R, Richa, Sinha AK, Sahal D.
    Eur J Med Chem; 2014 May 22; 79():350-68. PubMed ID: 24747290
    [Abstract] [Full Text] [Related]

  • 4. New syntheses and potential antimalarial activities of new 'retinoid-like chalcones'.
    Valla A, Valla B, Cartier D, Le Guillou R, Labia R, Florent L, Charneau S, Schrevel J, Potier P.
    Eur J Med Chem; 2006 Jan 22; 41(1):142-6. PubMed ID: 16274873
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
    Sashidhara KV, Avula SR, Palnati GR, Singh SV, Srivastava K, Puri SK, Saxena JK.
    Bioorg Med Chem Lett; 2012 Sep 01; 22(17):5455-9. PubMed ID: 22850213
    [Abstract] [Full Text] [Related]

  • 6. Synthesis of chiral chloroquine and its analogues as antimalarial agents.
    Sinha M, Dola VR, Soni A, Agarwal P, Srivastava K, Haq W, Puri SK, Katti SB.
    Bioorg Med Chem; 2014 Nov 01; 22(21):5950-60. PubMed ID: 25284252
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of artemisinin (qinghaosu) and chloroquine on drug-sensitive and drug-resistant strains of Plasmodium falciparum malaria: use of [2,8-3H]adenosine as an alternative to [G-3H]hypoxanthine in the assessment of in vitro antimalarial activity.
    Ye ZG, Van Dyke K, Wimmer M.
    Exp Parasitol; 1987 Dec 01; 64(3):418-23. PubMed ID: 3315734
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antiplasmodial activity of novel keto-enamine chalcone-chloroquine based hybrid pharmacophores.
    Sashidhara KV, Kumar M, Modukuri RK, Srivastava RK, Soni A, Srivastava K, Singh SV, Saxena JK, Gauniyal HM, Puri SK.
    Bioorg Med Chem; 2012 May 01; 20(9):2971-81. PubMed ID: 22464685
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.
    Tripathi R, Rizvi A, Pandey SK, Dwivedi H, Saxena JK.
    Acta Trop; 2013 May 01; 126(2):150-5. PubMed ID: 23391499
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis, Biological Evaluation, and Molecular Modeling Studies of Chiral Chloroquine Analogues as Antimalarial Agents.
    Kondaparla S, Debnath U, Soni A, Dola VR, Sinha M, Srivastava K, Puri SK, Katti SB.
    Antimicrob Agents Chemother; 2018 Dec 01; 62(12):. PubMed ID: 30224532
    [Abstract] [Full Text] [Related]

  • 15. Plasmodium yoelii nigeriensis: biological mechanisms of resistance to chloroquine.
    Beauté-Lafitte A, Altemayer-Caillard V, Chabaud AG, Landau I.
    Parasite; 1994 Sep 01; 1(3):227-33. PubMed ID: 9140489
    [Abstract] [Full Text] [Related]

  • 16. Repurposing of existing therapeutics to combat drug-resistant malaria.
    Yadav K, Shivahare R, Shaham SH, Joshi P, Sharma A, Tripathi R.
    Biomed Pharmacother; 2021 Apr 01; 136():111275. PubMed ID: 33485067
    [Abstract] [Full Text] [Related]

  • 17. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA, Ruenruetai U, Noor Rain A, Khozirah S, Zakiah I.
    Trop Biomed; 2006 Dec 01; 23(2):140-6. PubMed ID: 17322815
    [Abstract] [Full Text] [Related]

  • 18. Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains.
    Kondaparla S, Soni A, Manhas A, Srivastava K, Puri SK, Katti SB.
    Bioorg Chem; 2017 Feb 01; 70():74-85. PubMed ID: 27908538
    [Abstract] [Full Text] [Related]

  • 19. Oxygenated chalcones and bischalcones as potential antimalarial agents.
    Ram VJ, Saxena AS, Srivastava S, Chandra S.
    Bioorg Med Chem Lett; 2000 Oct 02; 10(19):2159-61. PubMed ID: 11012019
    [Abstract] [Full Text] [Related]

  • 20. Antimalarial activity of newly synthesized chalcone derivatives in vitro.
    Yadav N, Dixit SK, Bhattacharya A, Mishra LC, Sharma M, Awasthi SK, Bhasin VK.
    Chem Biol Drug Des; 2012 Aug 02; 80(2):340-7. PubMed ID: 22429524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.